Cadian Capital Management, LP Accelerate Diagnostics, Inc Transaction History

Cadian Capital Management, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$7.99 - $15.0 $714,833 - $1.34 Million	-89,466 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$9.98 - $18.04 $892,870 - $1.61 Million	89,466 New	89,466 $954,000
Q3 2019 Nov 13, 2019	SELL	$16.62 - $23.92 $279,631 - $402,454	-16,825 Closed	0 $0
Q2 2019 Aug 13, 2019	SELL	$17.79 - $22.88 $5 Million - $6.43 Million	-281,167 Reduced 94.35%	16,825 $385,000
Q1 2019 May 14, 2019	BUY	$11.76 - $22.15 $3.5 Million - $6.6 Million	297,992 New	297,992 $6.26 Million

549K

Ticker AXDX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 99,059,904
Market Cap $191M
Description
Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious ...

Get notified when there are updates to the investment portfolio of Cadian Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Cadian Capital Management, LP with notifications on news.